Spealman RD[au] - Search Results

Year	Number of Results
1974	1
1976	1
1977	1
1978	6
1979	5
1980	1
1981	4
1982	2
1983	5
1984	1
1985	4
1986	4
1987	3
1988	7
1989	5
1990	5
1991	6
1992	6
1993	1
1994	2
1995	4
1996	3
1997	2
1998	2
1999	4
2000	6
2001	5
2002	6
2003	7
2004	6
2005	4
2006	1
2007	3
2008	2
2009	6
2010	5
2011	2
2012	3
2015	3
2017	1
2019	1
2022	0

1

Dopaminergic signaling in dendritic spines.

Yao WD, Spealman RD, Zhang J. Yao WD, et al. Among authors: spealman rd. Biochem Pharmacol. 2008 Jun 1;75(11):2055-69. doi: 10.1016/j.bcp.2008.01.018. Epub 2008 Feb 12. Biochem Pharmacol. 2008. PMID: 18353279 Free PMC article. Review.

2

Pharmacological and environmental determinants of relapse to cocaine-seeking behavior.

Spealman RD, Barrett-Larimore RL, Rowlett JK, Platt DM, Khroyan TV. Spealman RD, et al. Pharmacol Biochem Behav. 1999 Oct;64(2):327-36. doi: 10.1016/s0091-3057(99)00049-0. Pharmacol Biochem Behav. 1999. PMID: 10515309 Review.

3

Behavioral and physiological effects of xanthines in nonhuman primates.

Howell LL, Coffin VL, Spealman RD. Howell LL, et al. Among authors: spealman rd. Psychopharmacology (Berl). 1997 Jan;129(1):1-14. doi: 10.1007/s002130050155. Psychopharmacology (Berl). 1997. PMID: 9122357 Review.

4

Drug self-administration by laboratory animals: control by schedules of reinforcement.

Spealman RD, Goldberg SR. Spealman RD, et al. Annu Rev Pharmacol Toxicol. 1978;18:313-39. doi: 10.1146/annurev.pa.18.040178.001525. Annu Rev Pharmacol Toxicol. 1978. PMID: 348062 Review. No abstract available.

5

Role of D1 and D2 dopamine receptors in the behavioral effects of cocaine.

Spealman RD, Bergman J, Madras BK, Kamien JB, Melia KF. Spealman RD, et al. Neurochem Int. 1992 Mar;20 Suppl:147S-152S. doi: 10.1016/0197-0186(92)90228-j. Neurochem Int. 1992. PMID: 1365414 Review. No abstract available.

6

Behavioral effects of cocaine and dopaminergic strategies for preclinical medication development.

Platt DM, Rowlett JK, Spealman RD. Platt DM, et al. Among authors: spealman rd. Psychopharmacology (Berl). 2002 Oct;163(3-4):265-82. doi: 10.1007/s00213-002-1137-8. Epub 2002 Jul 17. Psychopharmacology (Berl). 2002. PMID: 12373428 Review.

7

Behavioral Effects of Opioid Full and Partial Agonists During Chronic Buprenorphine Treatment.

Withey SL, Spealman RD, Bergman J, Paronis CA. Withey SL, et al. Among authors: spealman rd. J Pharmacol Exp Ther. 2019 Nov;371(2):544-554. doi: 10.1124/jpet.119.259010. Epub 2019 Aug 14. J Pharmacol Exp Ther. 2019. PMID: 31413139 Free PMC article.

8

Intravenous self-administration techniques in monkeys.

Platt DM, Carey G, Spealman RD. Platt DM, et al. Among authors: spealman rd. Curr Protoc Neurosci. 2005 Aug;Chapter 9:Unit 9.21. doi: 10.1002/0471142301.ns0921s32. Curr Protoc Neurosci. 2005. PMID: 18428630

9

Models of neurological disease (substance abuse): self-administration in monkeys.

Platt DM, Carey G, Spealman RD. Platt DM, et al. Among authors: spealman rd. Curr Protoc Pharmacol. 2011 Dec;Chapter 10:Unit10.5. doi: 10.1002/0471141755.ph1005s56. Curr Protoc Pharmacol. 2011. PMID: 22382996 Free PMC article.

10

Using behavior to elucidate receptor mechanisms: a review of the discriminative stimulus effects of benzodiazepines.

Lelas S, Spealman RD, Rowlett JK. Lelas S, et al. Among authors: spealman rd. Exp Clin Psychopharmacol. 2000 Aug;8(3):294-311. doi: 10.1037//1064-1297.8.3.294. Exp Clin Psychopharmacol. 2000. PMID: 10975618 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results